PAVmed (PAVM) Capital Expenditures (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 366.67% |
| Sep 30, 2025 | -62.50% |
| Jun 30, 2025 | 33.33% |
| Mar 31, 2025 | 50.00% |
| Jun 30, 2024 | -92.86% |
| Mar 31, 2024 | -77.05% |
| Dec 31, 2023 | 916.67% |
| Sep 30, 2023 | 20.00% |
| Jun 30, 2023 | -42.31% |
| Mar 31, 2023 | -91.28% |
| Dec 31, 2022 | -5.70% |
| Sep 30, 2022 | -10.23% |
| Jun 30, 2022 | -38.68% |
| Mar 31, 2022 | -55.05% |
| Dec 31, 2021 | 3,548.57% |
| Sep 30, 2021 | -71.07% |
| Jun 30, 2021 | 236.11% |
| Mar 31, 2021 | 350.00% |
| Dec 31, 2020 | 166.67% |
| Sep 30, 2020 | -92.86% |
| Jun 30, 2020 | 2,000.00% |
| Mar 31, 2020 | 0.00% |
| Jun 30, 2019 | 633.33% |
| Mar 31, 2019 | -4.61% |
| Sep 30, 2016 | 283.81% |
| Jun 30, 2016 | -84.71% |